Literature DB >> 26488281

Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Casey M Theriot1, Vincent B Young.   

Abstract

Antibiotics have significant and long-lasting effects on the intestinal microbiota and consequently reduce colonization resistance against pathogens, including Clostridium difficile. By altering the community structure of the gut microbiome, antibiotics alter the intestinal metabolome, which includes both host- and microbe-derived metabolites. The mechanisms by which antibiotics reduce colonization resistance against C. difficile are unknown yet important for development of preventative and therapeutic approaches against this pathogen. This review focuses on how antibiotics alter the structure of the gut microbiota and how this alters microbial metabolism in the intestine. Interactions between gut microbial products and C. difficile spore germination, growth, and toxin production are discussed. New bacterial therapies to restore changes in bacteria-driven intestinal metabolism following antibiotics will have important applications for treatment and prevention of C. difficile infection.

Entities:  

Keywords:  Clostridium difficile; antibiotics; bacterial metabolism; bile acids; colonization resistance; gut microbiota

Mesh:

Substances:

Year:  2015        PMID: 26488281      PMCID: PMC4892173          DOI: 10.1146/annurev-micro-091014-104115

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  137 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  Regulated transcription of Clostridium difficile toxin genes.

Authors:  B Dupuy; A L Sonenshein
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

4.  Glycan foraging in vivo by an intestine-adapted bacterial symbiont.

Authors:  Justin L Sonnenburg; Jian Xu; Douglas D Leip; Chien-Huan Chen; Benjamin P Westover; Jeremy Weatherford; Jeremy D Buhler; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 5.  Integration of metabolism and virulence in Clostridium difficile.

Authors:  Laurent Bouillaut; Thomas Dubois; Abraham L Sonenshein; Bruno Dupuy
Journal:  Res Microbiol       Date:  2014-10-15       Impact factor: 3.992

6.  The footprints of gut microbial-mammalian co-metabolism.

Authors:  Xiaojiao Zheng; Guoxiang Xie; Aihua Zhao; Linjing Zhao; Chun Yao; Norman H L Chiu; Zhanxiang Zhou; Yuqian Bao; Weiping Jia; Jeremy K Nicholson; Wei Jia
Journal:  J Proteome Res       Date:  2011-10-24       Impact factor: 4.466

7.  Dynamics and associations of microbial community types across the human body.

Authors:  Tao Ding; Patrick D Schloss
Journal:  Nature       Date:  2014-04-16       Impact factor: 49.962

8.  Carbohydrate fermentation by Clostridium difficile.

Authors:  S Nakamura; S Nakashio; K Yamakawa; N Tanabe; S Nishida
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

Review 9.  Amino acid metabolism in intestinal bacteria: links between gut ecology and host health.

Authors:  Zhao-Lai Dai; Guoyao Wu; Wei-Yun Zhu
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

10.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

View more
  104 in total

1.  Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.

Authors:  Brandon R Anjuwon-Foster; Natalia Maldonado-Vazquez; Rita Tamayo
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

2.  Misoprostol protects mice against severe Clostridium difficile infection and promotes recovery of the gut microbiota after antibiotic perturbation.

Authors:  Joseph P Zackular; Leslie Kirk; Bruno C Trindade; Eric P Skaar; David M Aronoff
Journal:  Anaerobe       Date:  2019-06-17       Impact factor: 3.331

3.  Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms.

Authors:  Jemila C Kester; Douglas K Brubaker; Jason Velazquez; Charles Wright; Douglas A Lauffenburger; Linda G Griffith
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile.

Authors:  Lucie Etienne-Mesmin; Benoit Chassaing; Oluwaseyi Adekunle; Lisa M Mattei; Frederic D Bushman; Andrew T Gewirtz
Journal:  Gut       Date:  2017-02-20       Impact factor: 23.059

Review 5.  Probiotics for prevention of Clostridium difficile infection.

Authors:  John P Mills; Krishna Rao; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2018-01       Impact factor: 3.287

Review 6.  Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.

Authors:  Jenessa A Winston; Casey M Theriot
Journal:  Anaerobe       Date:  2016-05-07       Impact factor: 3.331

7.  Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.

Authors:  Charles Burdet; Sakina Sayah-Jeanne; Thu Thuy Nguyen; Christine Miossec; Nathalie Saint-Lu; Mark Pulse; William Weiss; Antoine Andremont; France Mentré; Jean de Gunzburg
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 8.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

9.  Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.

Authors:  Peter Warn; Pia Thommes; Abdul Sattar; David Corbett; Amy Flattery; Zuo Zhang; Todd Black; Lorraine D Hernandez; Alex G Therien
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 10.  The Impact of Dietary Transition Metals on Host-Bacterial Interactions.

Authors:  Christopher A Lopez; Eric P Skaar
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.